Clinical Trial Update: Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating nab-paclitaxel, cetuximab, cisplatin, and radiation therapy for recurrent head and neck cancer has completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)
• Nab-paclitaxel (paclitaxel protein-bound)
• Radiation therapy

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-07-05